2005 Annual Meeting | Zebras or Quacks? Psychogenic and "Functional" Symptoms in Neurology
06:30 PM - 09:30 PM |
Dinner
|
|
06:45 PM - 07:30 PM |
Psychogenic Symptoms: Neurologic Aspects
Selim R. Benbadis, MD, FAAN |
|
07:30 PM - 08:15 PM |
The Assessment of Effort
David J. Williamson, PhD |
|
08:15 PM - 09:00 PM |
The Management of Psychogenic Symptoms
Francisco Fernandez, MD |
|
09:00 PM - 09:30 PM |
Questions and Answers
|
Selim R. Benbadis, MD, FAAN | Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stratus. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurelis. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB. |
David J. Williamson, PhD | Dr. Williamson has received personal compensation for serving as an employee of Janssen Scientific Affairs, LLC. Dr. Williamson has received stock or an ownership interest from Johnson & Johnson. |
Francisco Fernandez, MD | No disclosure on file |